Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Limited Disease Small Cell Lung Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT01262560
What this trial is testing

Manuka Honey in Preventing Esophagitis-Related Pain in Patients Receiving Chemotherapy and Radiation Therapy For Lung Cancer

Who this might be right for
DysphagiaLung CancerPain+1 more
Radiation Therapy Oncology Group 163
Testing effectiveness (Phase 2)Study completedNCT00554463
What this trial is testing

G-CSF and Pegfilgrastim in Treating Neutropenia in Patients Undergoing Radiation Therapy and Chemotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 5
Early research (Phase 1)Study completedNCT00005022
What this trial is testing

Radiation Therapy Plus Combination Chemotherapy in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Radiation Therapy Oncology Group 64
Testing effectiveness (Phase 2)Study completedNCT00072527
What this trial is testing

Cisplatin and Irinotecan Followed by Carboplatin, Etoposide, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology 78
Testing effectiveness (Phase 2)UnknownNCT04189094
What this trial is testing

Chemoradiotherapy With or Without Sintilimab in Limited-stage SCLC

Who this might be right for
Small Cell Lung Cancer Limited Stage
Zhejiang Cancer Hospital 140
Testing effectiveness (Phase 2)Study completedNCT00907569
What this trial is testing

Hypofractionated Radiotherapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Lung NeoplasmSmall Cell Carcinoma
AHS Cancer Control Alberta 2
Large-scale testing (Phase 3)Study completedNCT00031785
What this trial is testing

Megestrol in Treating Patients Who Are Undergoing Radiation Therapy for Lung Cancer

Who this might be right for
AnorexiaCachexiaLung Cancer
Wake Forest University Health Sciences 25
Large-scale testing (Phase 3)Study completedNCT00003917
What this trial is testing

Topotecan in Treating Patients With Relapsed Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Case Comprehensive Cancer Center 4
Testing effectiveness (Phase 2)Ended earlyNCT00887315
What this trial is testing

The Synergistic Metastases Annihilation With Radiotherapy and Docetaxel (Taxotere) [SMART] Trial for Non-Small Cell Lung Cancer (NSCLC)

Who this might be right for
Non-small Cell Lung Cancer
University of Chicago 11
Not applicableStudy completedNCT00303901
What this trial is testing

Cryotherapy in Treating Patients With Primary Lung Cancer or Lung Metastases That Cannot Be Removed By Surgery

Who this might be right for
Lung CancerMetastatic Cancer
Barbara Ann Karmanos Cancer Institute 40
Testing effectiveness (Phase 2)UnknownNCT04647357
What this trial is testing

A Trial of SHR-1316 Maintenance Therapy for Limited Stage Small Cell Lung Cancer

Who this might be right for
Limited-stage Small Cell Lung Cancer, LS-SCLC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology 60
Not applicableStudy completedNCT00572923
What this trial is testing

Concurrent Chemo-Radiotherapy for Limited Disease Small Cell Lung Cancer (LD-SCLC) on Basis of FDG-PET-Scans

Who this might be right for
Small Cell Lung Cancer
Maastricht Radiation Oncology 52
Testing effectiveness (Phase 2)Looking for participantsNCT06719700
What this trial is testing

Concurrent Chemoradiotherapy Combined With Toripalimab and Surufatinib in the Treatment of Limited-Stage Small Cell Lung Cancer

Who this might be right for
ToripalimabSurufatinibChemoradiotherapy+1 more
Sun Yat-sen University 47
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06914050
What this trial is testing

Hypofractionated Radiotherapy Followed by Chemo-immunotherapy Induction Therapy

Who this might be right for
Lung Cancer, Small CellLimited-stage Small Cell Lung Cancer (LS-SCLC)
Tianjin Medical University Cancer Institute and Hospital 30
Large-scale testing (Phase 3)Study completedNCT00538850
What this trial is testing

Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain

Who this might be right for
Cancer
INSYS Therapeutics Inc 130
Early research (Phase 1)Study completedNCT00036790
What this trial is testing

Motexafin Gadolinium and Doxorubicin in Treating Patients With Advanced Cancer

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersColorectal Cancer+9 more
University of Wisconsin, Madison
Large-scale testing (Phase 3)Active Not RecruitingNCT03703297
What this trial is testing

Study of Durvalumab + Tremelimumab, Durvalumab, and Placebo in Limited Stage Small-Cell Lung Cancer in Patients Who Have Not Progressed Following Concurrent Chemoradiation Therapy

Who this might be right for
Small Cell Lung Cancer
AstraZeneca 730
Testing effectiveness (Phase 2)Study completedNCT00387660
What this trial is testing

Irinotecan and Carboplatin in Treating Patients With Metastatic or Recurrent Small Cell Lung Cancer

Who this might be right for
Lung Cancer
University of California, Davis 80
Testing effectiveness (Phase 2)WithdrawnNCT00104754
What this trial is testing

Liposomal SN-38 in Treating Patients With Small Cell Lung Cancer

Who this might be right for
Lung Cancer
Alliance for Clinical Trials in Oncology
Testing effectiveness (Phase 2)Study completedNCT04735068
What this trial is testing

Binimetinib and Hydroxychloroquine in Patients With Advanced KRAS Mutant Non-Small Cell Lung Cancer

Who this might be right for
Non-Small Cell Lung CancerKRAS Mutation-Related Tumors
Abramson Cancer Center at Penn Medicine 9
Next Page